Investing Ideas
/
Austrian Pharmaceuticals & Biotech High Insider Buying

Austrian Pharmaceuticals & Biotech High Insider Buying

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

1 companies

Marinomed Biotech

Market Cap: €18.9m

Operates as a biopharmaceutical company in Austria, other European countries, and internationally.

MARI

€9.45

-9.1%

-50.3%